Higher Toxoplasma Gondii Seropositivity in COVID-19 and Tuberculosis Patients: A Case-Control Study

Abstract

Using a case-control study, we compared the antibody-positive profiles for Toxoplasma gondii in patients infected with SARS-CoV-2, tuberculosis (TB), HBV, and HIV-1 in Wuxi of China. As an important pathogen, Toxoplasma gondii has higher co-infection and reactivation rates in patients with SARSCoV-2 and TB infection.